Ledger.Open graph →
SEC Form D · filed December 19, 2016

Silver Creek Pharmaceuticals, Inc

Offering
$19.8M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ross Breckenridge · San Francisco, CAExec · DirectorTom Murtagh · San Francisco, CADirectorJames Marks · Kensington, CADirectorMichael Fairbanks · San Francisco, CADirectorUlrik Nielsen · San Francisco, CADirectorBirgit Schoeberl · San Francisco, CAExec · DirectorJames Marks · Kensington, CADirectorRoss Breckenridge · San Francisco, CAExec · DirectorMichael Fairbanks · San Francisco, CADirectorUlrik Nielsen · San Francisco, CADirectorTom Murtagh · San Francisco, CADirectorBirgit Schoeberl · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗